Pliant Return On Equity from 2010 to 2024

PLRX Stock  USD 13.34  0.13  0.98%   
Pliant Therapeutics Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity is likely to outpace its year average in 2024. Return On Equity is a measure of the profitability of Pliant Therapeutics in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.34)
Current Value
(0.32)
Quarterly Volatility
10.22727651
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pliant Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pliant Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Net Interest Income of 20.2 M or Interest Income of 21.5 M, as well as many indicators such as Price To Sales Ratio of 707, Dividend Yield of 0.0 or PTB Ratio of 2.36. Pliant financial statements analysis is a perfect complement when working with Pliant Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Pliant Therapeutics Correlation against competitors.
For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.

Latest Pliant Therapeutics' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Pliant Therapeutics over the last few years. Return on Equity is the amount of Pliant Therapeutics net income returned as a percentage of Pliant Therapeutics equity. Return on equity measures Pliant Therapeutics profitability by revealing how much profit Pliant Therapeutics generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Pliant Therapeutics' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pliant Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.4810 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Pliant Return On Equity Regression Statistics

Arithmetic Mean(1.11)
Geometric Mean1.91
Coefficient Of Variation(918.74)
Mean Deviation5.39
Median(6.17)
Standard Deviation10.23
Sample Variance104.60
Range40.4916
R-Value0.31
Mean Square Error101.75
R-Squared0.1
Significance0.26
Slope0.71
Total Sum of Squares1,464

Pliant Return On Equity History

2024 -0.32
2023 -0.34
2022 -0.39
2021 -0.09
2020 -0.14
2019 -0.43
2018 34.33

About Pliant Therapeutics Financial Statements

Pliant Therapeutics investors use historical fundamental indicators, such as Pliant Therapeutics' Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pliant Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity(0.34)(0.32)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.